Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Acorda Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 35 | 36 | +1 |
| Shares | 6.65M | 6.28M | −372.5K (−5.6%) |
| Value | $3.08M | $1.91M | −$1.17M (−38.0%) |
New holders (3)
Institutions that held Acorda Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 28,505 | $9.00K | 0.00% |
| BNP Paribas Arbitrage, SA | 607 | $181 | 0.00% |
| Citigroup Inc | 1,442 | $0 | 0.00% |
Sold out (2)
Institutions that held Acorda Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| HRT Financial LP | 39,319 | $18.0K |
| Ergoteles LLC | 13,300 | $6.00K |